Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
42171
CAS Number:
612847-09-3
AKT Inhibitor VIII
Purity:
≥ 97% (HPLC)
Synonym(s):
1,3-Dihydro-1-[1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenylmethyl]-4-piperidinyl]-2H-benzimidazol-2-one, Akti-1/2
Documents
$338.01 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

AKT Inhibitor VIII is a potent and selective inhibitor of the AKT signaling pathway, which plays a critical role in cell survival, growth, and metabolism. This compound is particularly valuable in cancer research, where dysregulation of the AKT pathway is often implicated in tumorigenesis. Researchers utilize AKT Inhibitor VIII to explore its effects on various cancer cell lines, providing insights into potential therapeutic strategies for targeting AKT-driven malignancies. Its unique structure allows for high specificity, making it a preferred choice for studies focused on the modulation of AKT activity without off-target effects.

In addition to its applications in oncology, AKT Inhibitor VIII is also being investigated for its role in neurodegenerative diseases and metabolic disorders, where AKT signaling is disrupted. The compound's ability to inhibit AKT can lead to decreased cell proliferation and increased apoptosis in cancer cells, making it a promising candidate for combination therapies. With its robust profile and targeted action, AKT Inhibitor VIII stands out as a critical tool for researchers aiming to unravel the complexities of AKT-related pathways and develop innovative treatments.

Synonyms
1,3-Dihydro-1-[1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenylmethyl]-4-piperidinyl]-2H-benzimidazol-2-one, Akti-1/2
CAS Number
612847-09-3
Purity
≥ 97% (HPLC)
Molecular Formula
C34H29N7O
Molecular Weight
551.65
MDL Number
MFCD09026909
PubChem ID
135398501
Appearance
White to yellow to orange powder or crystals
Conditions
Store at ≤ -4 °C
General Information
Synonyms
1,3-Dihydro-1-[1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenylmethyl]-4-piperidinyl]-2H-benzimidazol-2-one, Akti-1/2
CAS Number
612847-09-3
Purity
≥ 97% (HPLC)
Molecular Formula
C34H29N7O
Molecular Weight
551.65
MDL Number
MFCD09026909
PubChem ID
135398501
Appearance
White to yellow to orange powder or crystals
Conditions
Store at ≤ -4 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

AKT Inhibitor VIII is widely utilized in research focused on:

  • Cancer Research: This compound is instrumental in studying the AKT signaling pathway, which is often dysregulated in various cancers. By inhibiting AKT, researchers can explore potential therapeutic strategies to combat tumor growth.
  • Drug Development: It serves as a valuable tool in the development of new anti-cancer drugs. Its ability to selectively inhibit AKT activity allows scientists to test the efficacy of new compounds in preclinical models.
  • Neuroscience: The compound is also being investigated for its role in neuroprotection and neurodegenerative diseases. By modulating AKT pathways, it may help in understanding mechanisms of diseases like Alzheimer's and Parkinson's.
  • Metabolic Disorders: Researchers are exploring its effects on insulin signaling and glucose metabolism, making it relevant in studies related to diabetes and obesity.
  • Combination Therapies: AKT Inhibitor VIII is often used in combination with other treatments to enhance therapeutic effects, providing a multi-faceted approach to cancer treatment and improving patient outcomes.

Citations